Velarion Records
Free. Unsubscribe any time.

Apogee Therapeutics, Inc. (APGE)

Apogee Therapeutics, Inc. filed 47 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 103 transactions and 511,940 shares. None carries the SEC's AFF10B5ONE flag; all 47 name a plan in a footnote. 6 results prints are on file in the same window.

What stands out

Trades in Apogee Therapeutics, Inc. 103

Adoption dates in Apogee Therapeutics, Inc. 6

Results prints in Apogee Therapeutics, Inc. 6

Trades before a print in Apogee Therapeutics, Inc. 9

Interval to Apogee Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Apogee Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted on August 21, 2024”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.

The address of this record

Apogee Therapeutics, Inc.’s insider trading plan record — 47 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001974640.